MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Address
149 FIFTH AVENUE
NEW YORK, NY 10010
Founded
2017
Number of Employees
31
Website
http://www.minktherapeutics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at INKT make a trade.
Creating a free account takes less than one minute